Sarda Proteins Ltd Financials
Company Logo

Sarda Proteins Ltd Financial Statement

Sarda Proteins Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars
Sep 2024
Revenue0.14
Operating Expense0.04
Net Profit0.10
Net Profit Margin71.43
Earning Per Share0.61
EBIDTA0.10
Effective Tax RateTBA
Invest in Sarda Proteins Ltd
₹0 Brokerage*
Open Demat Account
*By signing up you agree to our Terms and Conditions

Sarda Proteins Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Total Revenue Annual1.30
Operating Expenses Annual1.44
Operating Profit Annual0.02
Interest Annual0.00
DepreciationTBA
Net Profit Annual0.02
Tax Annual-0.00

Sarda Proteins Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Cash Flow at the Beginning0.18
Cash Flow from Operations-0.23
Cash Flow from Investing0.17
Cash Flow from FinancingTBA
Cash Flow at the End0.12

Sarda Proteins Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
PBDIT Margin (%)1.54
PBIT Margin (%)1.54
PBT Margin (%)1.54
Net PROFIT Margin (%)1.54
Return On Networth / Equity (%)0.82
Return On Networth /Employed (%)0.81
Return On Assets (%)0.83
Total Debt / Equity (X)TBA
Asset Turnover Ratio (%)0.54

Sarda Proteins Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Fixed Assets Annual0.00
Total Current Assets Annual2.30
Non Current Assets Annual0.14
Total Shareholders Funds Annual2.37
Total Assets Annual2.43

Sarda Proteins Ltd Earning Calls

No Data Availabe

Get Your FAQs Right

As of Nov 23, 2024, Sarda Proteins Ltd has a market capitalization of 9.28 Cr. Value Research classifies it as a Micro-Cap company.
Yes, Sarda Proteins Ltd is debt-free with a debt-to-equity ratio of 0.00.
In FY 2023 , Sarda Proteins Ltd recorded a total revenue of approximately 1.30 Cr marking a significant milestone in the company's financial performance.
Sarda Proteins Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.2% and -1.1% annually, respectively..
Sarda Proteins Ltd's current PE ratio is 464.00.
Sarda Proteins Ltd's ROCE averaged 5.4% from the FY ending March 2022 to 2024, with a median of 0.8%. It peaked at 14.8% in March 2022, reflecting strong capital efficiency over the period..
Sarda Proteins Ltd's latest EBIT is Rs. 0.02 Cr, surpassing the average EBIT of Rs. 0.13 Cr over the 5 years..